Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the stem cell therapy market grown over the years?

The market for stem cell therapy has been expanding swiftly in the past few years. The expected expansion is from $7.86 billion in 2024 to reach $9.26 billion in 2025, giving it a compound annual growth rate (CAGR) of 17.7%. Factors contributing to the historical growth of this market include an increased rate of chronic illnesses, greater financial support from government and private entities, the fast-paced development of emerging markets, more investments made in cell and gene therapies, a rise in healthcare spending, and an upward trend in pharmaceutical research and development expenditure.

What Is the forecasted market size and growth rate for the stem cell therapy market?

The market size for orthopedic devices is projected to experience significant expansion in the coming years, escalating to $67.05 billion by 2029 with a 5.0% compound annual growth rate (CAGR). This predicted growth in the forecast period can be ascribed to the rise in value-based healthcare models, emphasis on sustainability, innovative strategies for joint preservation, and improved implant coatings and materials. Key trends that are expected to arise during the forecast period include intelligent orthopedic devices, the use of robotics in orthopedic surgeries, personalized orthopedic braces, the application of nanotechnology in orthopedics, and the incorporation of telemedicine in orthopedic care.

Get your stem cell therapy market report here!

https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

What are the major factors driving growth in the stem cell therapy market?

The escalation in the occurrence of chronic illnesses is leading to the expansion of the stem cell therapy market. Factors such as extended working hours, little physical exercise, and poor dietary choices are responsible for the heightened incidence of chronic diseases in individuals, therefore amplifying the demand for stem cell therapy. A United Nations article anticipates that by 2030, chronic diseases will be responsible for 70% of global deaths. Likewise, the global impact of chronic diseases is predicted to be around 60%. The increasing occurrence of chronic illnesses is anticipated to propel the growth of the stem cell therapy market.

What key areas define the segmentation of the global stem cell therapy Market?

The stem cell therapy market covered in this report is segmented –

1) By Type: Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy

2) By Cell Source: Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells

3) By Application: Musculoskeletal Disorders and Wounds & Injuries, Cancer, Autoimmune Disorders, Others

4) By End-Users: Hospitals And Clinics, Research Centers, Others.

Subsegments:

1) By Allogeneic Stem Cell Therapy: Derived From Donors (Related Or Unrelated), Used For Various Conditions, Including Blood Disorders And Certain Cancers, Examples Include Umbilical Cord Blood Stem Cells And Peripheral Blood Stem Cells

2) By Autologous Stem Cell Therapy: Derived From The Patient’s Own Cells, Used For Conditions Such As Orthopedic Injuries, Cardiac Diseases, And Certain Cancers, Involves The Harvesting Of Stem Cells From Tissues Like Bone Marrow Or Adipose Tissue

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3399&type=smp

What are the top market players propelling the growth of the stem cell therapy industry?

Major companies operating in the stem cell therapy market include Fujifilm Holding Corporation, Thermo Fisher Scientific Inc., Takara Bio Inc., MEDIPOST Co., Ltd., Astellas Pharma Inc., Catalent, Inc., Pharmicell Co., Ltd., JCR Pharmaceuticals Co., Ltd., Stemedica Cell Technologies, Inc., Pluristem Technologies Ltd, Becton Dickinson Private Limited, Stem Cell Technologies India Pvt. Ltd, Cordlife India Pvt. Ltd, Lifecell International Pvt. Ltd, Stemcyte India Therapeutics Private Limited, Stempeutics Research Private Limited, Anterogen Co., Ltd, Tonghua Dongbao Pharmaceutical Co, China Biologic Products Holdings Inc, Astrazenaca, Ablbio, Henlius, China Regenerative Medicine International, Innovent Biologics, Bio-Thera, Hisun Pharma, 3sbio, Beijing Shuanglu Pharmaceuticals, Qilu Pharmaceutical, Shanghai Fosun Pharmaceuticals, Cellerix, Cellgenix, Nsgene, Tigenix, Renuron Group, Smart Cells And Genenta Science, Amsterdam Molecular Therapeutics (Amt), Ark Therapeutics, Arthrogen Bv, Diamyd Medical Ab, Oxford Biomedica, Transgene, Mabion, Pure Biologics, Oncoarendi Therapeutics, Celon Pharma, Becton Dickinson And Company, Osiris Therapeutics, Capricortherapeutics, Cellular Dynamics Discgenics, Takeda Pharmaceuticals, Kolon Tissue Gene, Athersys, Cyro-Cell International, Geron Corporation, Mesoblast Ltd, Astrom Biosciences Inc, Invitrogen, Cytori Therapeutics Inc, Nuvasive Inc, Bristol-Myers Squibb Aldagen Inc, Caladrius Biosciences Inc, Biogen Sa, Daiichi Sankyo Co. Ltd, Gamida Cell Ltd, Gilead Sciences, Inc., Novartis Ag, Pfizer, Sanofi S.A.

What are the key trends shaping the future of the stem cell therapy market?

In the stem cell therapy market, the trend of companies entering into strategic collaborations is gaining traction. These partnerships, which are advantageous for both parties and involve entities that are not direct competitors, are on the rise. A case in point, SQZ Biotechnologies, a biotech firm from the US, collaborated with STEMCELL Technologies Inc., a Canadian biotech establishment in May 2022. Their project involves the creation and commercialization of a microfluidic intracellular delivery system for research purposes, based on SQZ’s Cell Squeeze technology. This would offer superior cell engineering assets to the life sciences sector for preliminary research. Both entities will disclose notable discoveries on the efficiency of this system in transporting cargoes to primary immune cell types. They will also illustrate advances in cell engineering employing mRNA and CRISPR/Cas9 in hematopoietic stem cells.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3399

What regions are dominating the stem cell therapy market growth?

North America was the largest region in the stem cell therapy market in 2024. The Middle East is expected to be the fastest-growing region in the global stem cell therapy market during the forecast period. The regions covered in the stem cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

3D Cell Culture Technologies Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/3d-cell-culture-technologies-global-market-report

Cell Therapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Flow Cytometry Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/flow-cytometry-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: